Workflow
力宝(00226) - 2023 - 年度业绩
LIPPOLIPPO(HK:00226)2024-03-27 13:22

Financial Performance - TIH Group's revenue for the year ended December 31, 2023, was HKD 813,522,000, representing a 20% increase from HKD 677,773,000 in 2022[8] - The total profit for the year was HKD 502,214,000, up from HKD 385,093,000 in the previous year, indicating a growth of approximately 30.5%[8] - The net loss for the year was HKD 68,682,000, a decline from a profit of HKD 144,111,000 in 2022, marking a turnaround of approximately 147.7%[8] - Basic and diluted earnings per share for the company were HKD (0.07), down from HKD 0.25 in the previous year[8] - The overall comprehensive loss for the year was HKD 293,212,000, compared to a loss of HKD 1,018,565,000 in the previous year, showing a significant improvement[11] - The company reported a pre-tax loss of HKD 67,045,000, indicating challenges in operational efficiency[69] - The company reported a pre-tax profit of HKD 144,197,000 for the year[70] - The group recorded a loss attributable to shareholders of HKD 35,000,000 for the year, compared to a profit of HKD 125,000,000 in 2022, primarily due to a decrease in profits from joint ventures[116] Revenue Breakdown - Revenue from food manufacturing business increased to HKD 324,523 thousand in 2023, up from HKD 266,461 thousand in 2022, representing a growth of 21.8%[27] - Restaurant operations revenue rose to HKD 359,901 thousand in 2023, compared to HKD 291,065 thousand in 2022, marking a significant increase of 23.5%[27] - Total revenue from customer contracts reached HKD 698,417 thousand in 2023, an increase of 21.8% from HKD 573,334 thousand in 2022[27] - The food business remains the primary revenue source, contributing 84% of total revenue in 2023, with a growth rate of 23%[87] - The revenue from the food business segment amounted to HKD 114,667,000, up from HKD 91,801,000 in 2022, indicating a year-over-year increase of about 25%[73] - The property investment segment generated total revenue of HKD 92,000,000, up from HKD 88,000,000 in 2022, mainly from recurring rental income and interest income from joint ventures[117] Joint Ventures and Investments - Healthway Group's share of profit for the year was HKD 8,000,000, a significant decrease from HKD 29,000,000 in 2022[4] - The group's share of results from joint ventures was HKD 169,707,000, a decrease from HKD 549,936,000 in 2022, representing a decline of approximately 69%[8] - The group's share of profit from its investment in LAAPL was HKD 174 million for the year, down from HKD 554 million in 2022[91] - The group has a significant investment in OUE Limited, a leading real estate development and management company in Asia[51] Assets and Liabilities - Total assets as of December 31, 2023, amounted to HKD 14,091,684 thousand, slightly down from HKD 14,180,190 thousand in 2022[31] - The company's equity attributable to equity holders decreased to HKD 9,075,231 thousand in 2023 from HKD 9,300,008 thousand in 2022, a decline of 2.4%[32] - Total liabilities stood at HKD 2,220,208,000, with a significant portion attributed to undistributed liabilities of HKD 1,390,536,000[69] - The group's total liabilities decreased to HKD 2,200,000,000 as of December 31, 2023, down from HKD 2,400,000,000 in 2022[135] Cash Flow and Financing - Cash and cash equivalents decreased to HKD 454,717 thousand in 2023 from HKD 868,547 thousand in 2022, a reduction of 47.7%[31] - The group's unsecured other loans increased to HKD 250,000,000 from HKD 70,000,000 in the previous year, reflecting a significant rise of 257%[5] - The group's financing costs rose to HKD 111,030,000 from HKD 71,263,000, indicating an increase of 56%[8] - The company incurred a financing cost of HKD 145,149,000, impacting overall profitability[69] Operational Challenges - The group continues to face challenges in the food business due to intense competition, labor shortages, and rising operational costs, impacting overall performance[66] - The group remains engaged in ongoing litigation related to claims against and counterclaims from its major investors, with the court proceedings still in progress[56] - The company has not been affected by the new tax legislation under the OECD's Pillar Two framework, as it does not fall within its scope[38] Future Outlook - The company plans to continue expanding its market presence and investing in new product development to drive future growth[70] - The geopolitical risks from conflicts in Ukraine and the Middle East may continue to impact global trade and investment, affecting the economic outlook for 2024[140] - The group will remain vigilant and actively seek opportunities arising from corporate deleveraging and non-core asset sales[134]